Bretylium

GeriatricPediatric
  • TRADE NAMES: Bretylate; Critifib
  • INDICATIONS: Ventricular tachycardia and fibrillation
  • CLASS: Antiarrhythmic class III
  • HALF-LIFE: 4–17 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Arsenic, Astemizole, Ciprofloxacin, Enoxacin, Gatifloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Quinolones, Sparfloxacin

PREGNANCY CATEGORY: C

Our database has 10 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
OTHER.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top